Entity Details

Primary name LOXL1_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ08397
EntryNameLOXL1_HUMAN
FullNameLysyl oxidase homolog 1
TaxID9606
Evidenceevidence at protein level
Length574
SequenceStatuscomplete
DateCreated2001-04-27
DateModified2021-06-02

Ontological Relatives

GenesLOXL1

GO terms

Show/Hide Table
GOName
GO:0001669 acrosomal vesicle
GO:0004720 protein-lysine 6-oxidase activity
GO:0005507 copper ion binding
GO:0005576 extracellular region
GO:0005604 basement membrane
GO:0005615 extracellular space
GO:0018057 peptidyl-lysine oxidation
GO:0018277 protein deamination
GO:0030198 extracellular matrix organization
GO:0030199 collagen fibril organization
GO:0032496 response to lipopolysaccharide
GO:0035904 aorta development
GO:0062023 collagen-containing extracellular matrix

Subcellular Location

Show/Hide Table
Subcellular Location
Secreted

Domains

Show/Hide Table
DomainNameCategoryType
IPR001695 Lysyl oxidaseFamilyFamily
IPR019828 Lysyl oxidase, conserved siteSiteConserved site

Diseases

Show/Hide Table
Disease IDSourceNameDescription
177650 OMIMExfoliation syndrome (XFS)A disorder characterized by accumulation of abnormal fibrillar deposits in the anterior segment of the eye. In addition to being a cause of glaucoma and glaucomatous optic neuropathy, exfoliation syndrome has also been associated with lens zonule weakness, cataract formation, and systemic vascular complications due to deposition of exfoliation material in extraocular tissues. Disease susceptibility is associated with variants affecting the gene represented in this entry. Susceptibility to exfoliation syndrome is conferred by a risk haplotype that includes two LOXL1 coding non-synonymous SNPs (Arg141Leu and Gly153Asp) and one intronic SNP. Arg141Leu and Gly153Asp are sufficient to confer disease susceptibility in some populations.